Advanced Clinical Practice: Botulinum Toxin Type A for the Treatment of Urinary Tract Dysfunction in Neurological Disorders

Identification: unj_ja10_03
Issue: July-August 2010
Volume: Volume 30 Number 4


Acknowledgment: The authors thank Janet Manfre; Wolters Kluwer Pharma Solutions; for editorial assistance in the preparation of this manuscript. Funding for editorial assistance was provided by Allergan; Inc.


Credits: None available.

You must be logged in and own this product in order to post comments.